NR3C1 and metabolic syndrome: Other examples include reduced methylation of the peroxisome proliferator-activated receptor alpha (PPARα) and glucocorticoid receptor (GR) genes; increased expression of these genes is associated with an increased risk of metabolic syndrome and cardiovascular disease [65].